Izotropic’s IzoView Breast CT Device Stands Distinct vs Existing Breast Imaging Technologies
IzoView positioned to disrupt high-growth breast imaging markets with target device price of USD $500K IzoView to launch into projected fastest-growing imaging category with potential to displace well-established technologies Differentiated from existing device types through upgradeability, pipeline, and platform business model VANCOUVER, British Columbia, and SACRAMENTO, Calif., July 29, 2025 (GLOBE NEWSWIRE) -- via IBN -Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) (“Izotropic”, or the “Company”), a medical device…